Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma

IntroductionBile duct cancer (cholangiocarcinoma, CCA) has a poor prognosis for patients, and despite recent advances in targeted therapies for other cancer types, it is still treated with standard chemotherapy. Anaplastic lymphoma kinase (ALK) has been shown to be a primary driver of disease progre...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Kyaw Zwar Myint, Mireia Sueca-Comes, Pamela Collier, Brinda Balasubramanian, Simran Venkatraman, John Gordan, Abed M. Zaitoun, Abhik Mukherjee, Arvind Arora, Noppadol Larbcharoensub, Chinnawut Suriyonplengsaeng, Kanokpan Wongprasert, Tavan Janvilisri, Dhanny Gomez, Anna M. Grabowska, Rutaiwan Tohtong, David O. Bates, Kiren Yacqub-Usman
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2023-12-01
סדרה:	Frontiers in Oncology
נושאים:	cholangiocarcinoma Opisthorchis viverrini anaplastic lymphoma kinase 1 novel therapeutics cytotoxicity and autophagy
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1184900/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!